Medicines List

Select category
  • Description

    Clopasa contains the active substance colchicine and belongs to the group of medicines known as antigout drugs.

    Indications

    Clopasa is used for the treatment of acute gout attacks and chronic gout, prophylaxis of acute attacks,  when starting treatment with other medicines decreasing uric acid in blood and urine, and Familiar Mediterranean Fever.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 0,5 mg tablets

  • Description

    Reverantza contains two substances called olmesartan medoxomil and amlodipine.
    Both of these substances help to control high blood pressure.

    Olmesartan medoxomil belongs to a group of medicines called ‘angiotensin-II receptor antagonists’ which lower blood pressure by relaxing the blood vessels.

    Amlodipine belongs to a group of substances called ‘calcium channel blockers’. Amlodipine stops calcium from moving into the blood vessel wall which stops the blood vessels from tightening thereby also reducing blood pressure.

    Indications

    Treatment of essential hypertension.
    Reverantza is indicated in adult patients whose blood pressure is not adequately controlled on olmesartan medoxomil or amlodipine monotherapy.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 20 mg/5 mg; 40 mg/5 mg film-coated tablets.

  • Description

    Methylprednisolone-Tchaikapharma belongs to a group of medicines called corticosteroids or steroids.

    Indications

    Methylprednisolone-Tchaikapharma is used to treat the following conditions:
    – Hormonal diseases;
    – Rheumatic diseases;
    – Collagenosis;
    – Skin diseases;
    – Allergic conditions;
    – Eye diseases;
    – Intestinal diseases;
    – Pulmonary inflammation;
    – Blood disorders;
    – Malignancies;
    – Swelling;
    – Other conditions.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 40 mg powder and solvent for solution for injection

  • Description

    TromBye contains the active ingredient cilostazol, which belongs to a group of medicines called phosphodiesterase type 3 inhibitors.
    Its actions are several and include dilating some blood vessels and reducing the clotting activity (to stick together) of some blood cells, called platelets, in the blood vessels.
    TromBye has been prescribed for “intermittent claudication”. It is a spasmodic pain in the legs when walking and is caused by insufficient blood supply to the legs.

    Indications

    TromBye has been shown to improve the maximum and painless walking distance in patients with intermittent claudication who are painless at rest and without evidence of peripheral tissue necrosis (stage II peripheral arterial disease according to Fontaine).
    TromBye is intended for use as a second-line agent in patients in whom lifestyle changes (including smoking cessation and controlled exercise programs) and other appropriate interventions have not sufficiently improved the symptoms of intermittent claudication.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 100 mg tablets